Device platforms

Device platforms like autoinjectors provide reliable, user-friendly solutions for self-administering medications. Engineered for consistent dosing, they improve patient adherence, safety, and comfort. With customizable features, autoinjectors cater to diverse therapeutic needs, enhancing drug delivery and patient care. At SHL Medical, we offer multiple device platforms for both pre-filled syringes and cartridges, including a versatile model compatible with both formats.

Check our products

Molly® - SHL Medical’s modular platform autoinjector

As more platform products enter the autoinjector market, we set out to revolutionize the impact of platform technologies on the industry. This vision led to the creation of the Molly modular platform, an adaptable solution designed to combine the strengths of a platform approach with enhanced flexibility in design, development, and production. Today, the Molly® platform is widely utilized for treating cardiometabolic conditions, including obesity, and serves as the delivery device for popular weight-loss drugs, showcasing its critical role in supporting modern therapeutic needs.

Read more about Molly at Success stories

Molly-and-Molly-2.25-autoinjector-slider-1-1

Advantages of SHL Medical platforms

Partnering with SHL Medical means comprehensive support for your drug delivery development project from start to finish. Here are the key advantages of utilizing the Molly® platform to bring your drug to market.

Smart investment

Investing in SHL Medical's self-injection device platform represents a strategic decision for customers. With access to an established manufacturing infrastructure, they can utilize our in-house assets or opt to invest in their own. This approach minimizes the risks typically associated with capital investments, allowing for seamless integration into the Molly platform.

North Charleston USA Facility-20240612-4

Faster development times

SHL Medical's platform accelerates development timelines, leveraging over 30 years of expertise in self-injection solutions. Customers benefit from a wide range of customization options and future-proof technologies that address the growing demands for digital connectivity and sustainability. This scalability ensures efficient production, whether for low or high volumes.

Reduced risks and cost

Partnering with SHL Medical significantly reduces risks and costs for customers. The platform is backed by a robust portfolio of patent families and offers extensive customization options. It provides a highly reliable solution that guarantees a safe and easy injection experience for patients, enhancing overall satisfaction and confidence in the product.

Our device platforms

Molly®

Viscosity

Volume

Built on a modular platform technology, Molly® is designed to meet the evolving requirements of future autoinjectors, such as introducing unique designs for branding and user requirements, as well as high-volume manufacturing.

The Molly autoinjector is designed with an ergonomic body and a flange-shaped anti-roll cap for an easier handling experience.

Molly® 2.25

Viscosity

Volume

Molly® 2.25 is a large-volume variant of the Molly autoinjector to accommodate larger-volume biologics. Featuring the same easy-to-use, 2-step operation, it inherited the modular platform development model to support high-volume manufacturing, faster development, and flexible design for unique branding needs.

Maggie®

Viscosity

Volume

Maggie® accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors

Maggie® 5.0

Viscosity

Volume

Maggie® 5.0 mL accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors.

Elexy™

Elexy™ aims to provide a best-in-class user experience and a wide range of injection profiles. Comprised of a reusable power unit and disposable drug cassettes, the Elexy system is compatible with both pre-filled syringe (PFS) and cartridge primary containers and, capable of delivering up to 5.0 mL in a single injection.